Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-05-11
1995-12-05
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
5147722, 5147723, 5147726, 514773, 514777, 514779, 514781, 536103, A61K 4748, A61K 31735, C08B 3716
Patent
active
054729548
ABSTRACT:
The invention provides a method for enhancing the complexation of a cyclodextrin with a lipophilic and/or water-labile active ingredient which is a drug, cosmetic additive, food additive or agrochemical, comprising combining from about 0.1 to about 70% (weight/volume) of a cyclodextrin, from about 0.001 to about 5% (weight/volume) of a pharmacologically inactive water-soluble polymer acceptable for use in a pharmaceutical, cosmetic, food or agricultural composition, and said lipophilic and/or water-labile active ingredient in an aqueous medium, the polymer and cyclodextrin being dissolved in the aqueous medium before the active ingredient is added, the aqueous medium which comprises the polymer and cyclodextrin being maintained at from about 30.degree. to 150.degree. C. for a period of from about 0.1 to about 100 hours before, during and/or after the active ingredient is added, optionally followed by removal of water. Related methods, co-complexes of active ingredient/cyclodextrin/polymer, pharmaceutical, cosmetic, food and agricultural compositions and cyclodextrin/polymer complexing agents are also provided.
REFERENCES:
patent: 3459731 (1969-08-01), Gramera et al.
patent: 4426292 (1984-01-01), Wernick et al.
patent: 4596795 (1986-06-01), Pitha
patent: 4727064 (1988-02-01), Pitha
patent: 4834985 (1989-05-01), Elger et al.
patent: 4883785 (1989-11-01), Chow et al.
patent: 4983586 (1991-01-01), Bodor
patent: 5002935 (1991-03-01), Bodor
patent: 5017566 (1991-05-01), Bodor
patent: 5024998 (1991-06-01), Bodor
patent: 5070081 (1991-12-01), Majid et al.
patent: 5120546 (1992-06-01), Hansen et al.
patent: 5321014 (1994-06-01), Janz et al.
patent: 5324718 (1994-06-01), Loftsson
Villiers, C. R. Acad. Sci., 112, 536-538(1891).
Schardinger, Z Unters. Nahr. Genussm., 6, 865-880(1903).
Szejtli, Pharm. Techn. Int., 3(2), 15-22(1991).
Szejtli, Pharm. Techn. Int., 16-24(1991).
Loftsson et al, Pharm. Ztg. Wiss., 4/136:5-10(1991).
Hirayama et al, in Cyclodextrins and their industrial uses, ed. D. Duchene, Editions de Sante, Paris, 1987, pp. 133-172.
Hassan et al, Int. J. Pharm. 58, 19-24(1990).
Nakai et al, Chem. Pharm. Bull, 35(11), 4609-4615(1987).
Nakai et al, Chem. Pharm. Bull, 37(4), 1055-1058(1989).
Nakai et al, Chem. Pharm. Bull, 38(3), 728-732(1990).
Nakai et al, Chem. Pharm. Bull., 38(5), 1345-1348(1990).
Nakai et al, Chem. Pharm. Bull., 39(6), 1532-1535(1991).
Schmidt et al, Starch/Starke, 39(6), 203-207 (1987).
Loftsson et al, Acta. Pharm. Nord, 1(4), 185-193(1989).
Remington's Pharmaceutical Sciences, 18th edition, Alfonso R. Gennaro (ed.), Mack Publishing Co., Easton, Pa., 1990, pp. 291-294.
Martin et al, Physical Pharmacy, 3rd edition, Lea & Febinger, Philadelphia, Pa. 1983, pp. 592-638.
Florence et al, Physiochemical Principles of Pharmacy, 2nd edition, MacMillan Press, London, 1988, pp. 281-334.
Leung et al, in Controlled Drug Delivery, 2nd edition, Robinson and Lee, editors, Marcel Dekker, Inc., New York, 1987, pp. 433-480.
Uekama et al, Journal of Inclusion Phenomena, 1, 309-312(1984).
Pagington, J. S., ".beta.-cyclodextrin: the success of molecular inclusion," in Chemistry in Britain, May 1987, 455-458.
Loftsson et al, Eur. J. Pharm. Biopharm., vol. 37, No. 1, Mar. 1991, 30-33.
STN FILE SUPPLIER & FILE MEDLINE AN=92324215 (Orienti et al).
Chemical Abstracts, vol. 107, No. 16, 1987, abstract No. 140916f.
DATABASE WPI, Week 9037, Derwent Pulication Ltd., London, GB, AN 90-279330.
THE MERCK INDEX, eleventh edition, ed. Susan Budavari et al, Merck & Co., Inc. Rahway, N.J., 1989, pp. 959, 1248 and 1467.
COSMETIC AND DRUG PRESERVATION: PRINCIPLES AND PRACTICE, ed. Jon J. Kabara, Marcel Dekker, Inc., New York, N.Y., 1984, pp. 71-72.
THE UNITED STATES PHARMACOPEIA, USP XXII, twenty-second revision, Jan. 1, 1990, U.S. Pharmacopeial Convention, Inc. Rockville, Md., p. 8.
Loftsson et al, European Journal of Pharmaceutical Sciences, 1(1994), 175-180.
Loftsson et al, International Journal of Pharmaceutics, 104(1994), 181-184.
Loftsson et al, "Topical acetazolamide-HP.beta.CD eye drop solution," in Final Program and Abstracts for the 7th International Cyclodextrins Symposium, Tokyo, Japan, Apr. 25-28, 1994, p. 112, abstract P-B-25.
Loftsson et al, "Dexamethasone 2-hydroxypropyl-.beta.-cyclodextrin eye drops," In Final Program and Abstracts for the 7th International Cyclodextrins Symposium, Tokyo, Japan, Apr. 25-28, 1994, p. 113, abstract P-B-26.
Loftsson et al, "The Effect of Polymers on Cyclodextrin Complexation," in Final Program and Abstracts for the 7th International Cyclodextrins Symposium, Tokyo, Japan, Apr. 25-28, 1994, p. 114, abstract P-B-27.
Stefansson et al, "Dexamethasone 2-Hydroxypropyl-.beta.-cyclodextrin (HP.beta.CD) Eye Drops," in Investigative Ophthalmology & Visual Science, Annual Meeting Abstract Issue, Mar. 15, 1994, vol. 35, No. 4, p. 2217, abstract 4459-11.
Thorisdottir et al, "Topical Acetazolamide in 2-Hydroxypropyl-.beta.-Cyclodextrin (HP.beta.CD) Eye Drops Lowers Intraocular Pressure in Humans," in Investigative Ophthalmology & Visual Science, Annual Meeting Abstract Issue, Mar. 15, 1994, vol. 35, No. 4, p. 2220, abstract 4479-4531.
Florence et al, Physiochemical Principles of Pharmacy, 2nd ed., Macmillan Press, London 1988, pp. 24, 297-298.
Higuchi, J. Soc. Cosm. Chem., 11, 85-97(1960).
Loftsson, Arch. Pharm. Chem., Sci. Ed., 10, 17-24(1981).
Chien, Novel Drug Delivery Systems, 2nd Ed., Marcel Dekker, New York 1992, pp. 171-173.
Peppas et al, "Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues," in J. M. Anderson and S. W. Kim (editors), Advances in Drug Delivery Systems, Elsevier, Amsterdam 1986, pp. 257-275.
Attwood et al: Surfactant Systems. Their Chemistry, Pharmacy and Biology, Chapman and Hall, London, 1983, pp. 361-365.
Myers, Surfactant Science and Technology, VCH Publishers, New York, 1988, pp. 142-145.
Cyclops h.f.
Griffin Ronald W.
LandOfFree
Cyclodextrin complexation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclodextrin complexation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclodextrin complexation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1374258